Akumin to Host First Quarter 2022 Financial Results Call on May 11, 2022

Rhea-AI Summary

Akumin Inc. (NASDAQ: AKU) will host a conference call on May 11, 2022, at 8:30 a.m. Eastern Time to discuss its first quarter 2022 financial results. The results will be released on May 10, 2022. Participants can join the call by registering at this link or by accessing the webcast at here. A replay will be available until May 18, 2022. Akumin offers diagnostic imaging and oncology services across the U.S., with approximately 200 imaging locations and partnerships with about 1,000 hospitals.

Positive

• Strong positioning as a national partner in radiology and oncology services.
• Broad network with approximately 200 imaging locations enhancing service delivery.
• Affiliated with around 1,000 hospitals and health systems.

Negative

• None.

PLANTATION, Fla., May 5, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ: AKU) (TSX: AKU) ("Akumin" or the "Company") will host a conference call at 8:30 a.m. Eastern Time, May 11, 2022, to discuss its first quarter 2022 financial results. The financial results are expected to be available on Tuesday, May 10, 2022.

To access the conference call, participants may join by registering for the conference at https://akum.in/Q1-2022-Results-Audio or via webcast at https://akum.in/Q1-2022-Results-Webcast. A related presentation will be available from Akumin's website (www.akumin.com). Participants are asked to connect at least 10 minutes prior to the beginning of the call to ensure participation. The webcast archive will be available for 90 days. A replay of the presentation will also be available until Wednesday, May 18, 2022, by calling 647-436-0148 or toll-free 1-888-203-1112, using passcode number 8269616.

About Akumin

Akumin is a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service line needs. Akumin provides (1) fixed-site outpatient diagnostic imaging services through a network of approximately 200 owned and/or operated imaging locations; and (2) outpatient radiology and oncology services and solutions to approximately 1,000 hospitals and health systems across 48 states. By combining clinical and operational expertise with the latest advances in technology and information systems, Akumin facilitates more efficient and effective diagnosis and treatment for patients and their providers. Akumin's imaging procedures include MRI, CT, positron emission tomography (PET and PET/CT), ultrasound, diagnostic radiology (X-ray), mammography, and other interventional procedures; our cancer care services include a full suite of radiation therapy and related offerings. For more information, visit www.akumin.com and www.alliancehealthcareservices-us.com.

Forward-Looking Information

Certain information in this press release constitutes forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates and projections regarding future events. Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Akumin as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including, but not limited to, the factors described in greater detail in the "Risk Factors" section of Akumin's Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on March 16, 2022, as amended by Amendment No. 1 to Form 10-K, filed with the SEC on April 12, 2022 (the "2021 Annual Report"), which is available at www.sedar.com and www.sec.gov. These factors are not intended to represent a complete list of the factors that could affect Akumin; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this press release are made as of the date of this press release, and Akumin expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law. For further information:

View original content:https://www.prnewswire.com/news-releases/akumin-to-host-first-quarter-2022-financial-results-call-on-may-11-2022-301540612.html

SOURCE Akumin Inc.

FAQ

When is Akumin's first quarter 2022 financial results call?

Akumin's conference call for the first quarter 2022 financial results is scheduled for May 11, 2022, at 8:30 a.m. Eastern Time.

Where can I find Akumin's first quarter 2022 financial results?

The financial results for Akumin's first quarter 2022 will be available on May 10, 2022.

How can I access the Akumin financial results conference call?

You can access the Akumin financial results conference call by registering at their website or via their webcast.

What services does Akumin provide?

Akumin provides diagnostic imaging services and oncology solutions, including MRI, CT, PET, ultrasound, and radiation therapy.